About
ARS Pharmaceuticals
SPRY.US
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally. The company is involved in the development of neffy, a needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Profile
- Company Name
- ARS Pharmaceuticals, Inc.
- Market
- NasdaqGM
- Founded
- Industry
- --
- Fiscal Year End
- December 31
- Website
- ars-pharma.com